ERBB2 and breast cancer: In conclusion, genomic analysis using MIP microarray provides accurate and quantitative assessment of breast cancer-related oncogenes including HER2 and FGFR1. Global genomic CNA and chromothripsis-like patterns occur frequently in advanced breast cancer.